(Wegovy, Mounjaro & the New Pill, 2026) Updated 22/06/26 Based on the available clinical evidence, Mounjaro (tirzepatide) and Wegovy (semaglutide) are both well tolerated, but most people find Mounjaro causes fewer gastrointestinal side effects at comparable doses, with lower rates of nausea and a higher likelihood of completing treatment
Pedersen C, Lefevre S, Peters V, Patterson M, Ghatei MA, Morgan LM, et al
Zepbound is approved for those with a BMI of 30 or greater
They work through entirely different mechanisms and dont share metabolic pathways in ways that create a known drug-drug interaction
Minor intestinal issues at highest dose
How Physicians Reduce Semaglutide Side Effects Managing side effects is a routine and expected part of treatment